News for Codexis, Inc. (CDXS)

At the TIDES USA meeting in San Diego, Codexis (CDXS) unveiled advancements in its ECO Synthesis platform, emphasizing its role in siRNA manufacturing. The plat

**media[633485]**

Summary Mirum Pharmaceuticals Inc (MIRM) announced the appointment of Doug Sheehy, JD, as the new chief legal officer. With nearly two decades of experience in

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced the appointment of Doug Sheehy, JD, as chief legal officer. Mr. Sheehy brings nearly two decades of

Operator: Greetings and welcome to the Codexis First Quarter 2025 Earnings Conference Call and webcast. At this time, all participants are in a listen-only mode.

Release Date: May 14, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Codexis Inc (CDXS

The following slide deck was published by Codexis, Inc.

Gain insights from Codexis Q1 2025 earnings, highlighting strong financial guidance, ecosystem platform progress, and growing traction for RNA therapeutics.

Codexis, Inc. (NASDAQ:CDXS) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ETCompany ParticipantsCarrie McKim - Director of Investor RelationsStephen...

**media[617225]**

On March 31, 2025, BlackRock, Inc. (Trades, Portfolio) executed a significant transaction involving Codexis Inc. by reducing its holdings by 1,663,127 shares. T

REDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. ( CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeut

**media[600861,600862]**

REDWOOD CITY, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable th

Codexis (CDXS) announces the retirement of Byron Dorgan from its Board of Directors at the 2025 Annual Meeting of Stockholders. The board will reduce fr

**media[590917]**

**media[582597]**

On March 21, 2025, Opaleye Management Inc. (Trades, Portfolio) executed a significant transaction by acquiring an additional 350,000 shares of Codexis Inc. This

Represents first project to enter the ECO Synthesisâ„¢ Innovation Lab Core enzymes for ECO Synthesisâ„¢ technology have transitioned from research into develop